Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives

• Main Authors: Giovanni Taccetti (Author), Michela Francalanci (Author), Giovanna Pizzamiglio (Author), Barbara Messore (Author), Vincenzo Carnovale (Author), Giuseppe Cimino (Author), Marco Cipolli (Author)
• Format: Book
• Published: MDPI AG, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Although new inhaled antibiotics have profoundly improved respiratory diseases in cystic fibrosis (CF) patients, lung infections are still the leading cause of death. Inhaled antibiotics, i.e., colistin, tobramycin, aztreonam lysine and levofloxacin, are used as maintenance treatment for CF patients...